Massive parallel sequencing applied to the molecular autopsy in sudden cardiac death in the young

Forensic Science International: Genetics

Volumn 18, Issue , 2015, Pages 160-170

  Brion, M ^a,b   Sobrino, B ^b   Martinez, M ^a,b   Blanco Verea, A ^a,b   Carracedo, A ^b,c,d  

^a Instituto de Investigación Sanitaria de Santiago de Compostela IDIS   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^d KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Genomic autopsy; Next generation sequencing; Sudden cardiac death

Indexed keywords

CALSEQUESTRIN; CARDIAC MYOSIN; FILAMIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; ION CHANNEL; MYOSIN HEAVY CHAIN BETA; POTASSIUM CHANNEL; POTASSIUM CHANNEL KCNQ1; RYANODINE RECEPTOR 2; SODIUM CHANNEL NAV1.5;

ADULT; ARTICLE; AUTOPSY; BRUGADA SYNDROME; CARDIOMYOPATHY; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CAUSE OF DEATH; CONGESTIVE CARDIOMYOPATHY; DESMOSOME; FORENSIC GENETICS; FORENSIC IDENTIFICATION; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC SCREENING; GENOMICS; GENOTYPE PHENOTYPE CORRELATION; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INDEL MUTATION; LIBRARY; LONG QT SYNDROME; NEXT GENERATION SEQUENCING; PHENOTYPE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SARCOMERE; SHORT QT SYNDROME; SOLUTION HYBRIDIZATION; SUDDEN CARDIAC DEATH; YOUNG ADULT; GENETICS; HIGH THROUGHPUT SEQUENCING; INCIDENCE; PATHOLOGY; PROCEDURES; REPRODUCIBILITY;

ADULT; AUTOPSY; CARDIOMYOPATHIES; DEATH, SUDDEN, CARDIAC; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INCIDENCE; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 84939570313     PISSN: 18724973     EISSN: 18780326     Source Type: Journal    
DOI: 10.1016/j.fsigen.2015.07.010     Document Type: Article

References (72)

1. R.F. Marsman, H.L. Tan, and C.R. Bezzina Genetics of sudden cardiac death caused by ventricular arrhythmias Nat. Rev. Cardiol. 11 2 2014 96 111
2. R. Margey, A. Roy, S. Tobin, C.J. O'Keane, C. McGorrian, and et al. Sudden cardiac death in 14- to 35-year olds in ireland from 2005 to 2007: a retrospective registry Europace 13 10 2011 1411 1418
3. S.G. Priori, A.A. Wilde, M. Horie, Y. Cho, E.R. Behr, and et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013 Heart Rhythm 10 12 2013 1932 1963
4. R.D. Bagnall, K.J. Das, J. Duflou, and C. Semsarian Exome analysis-based molecular autopsy in cases of sudden unexplained death in the young Heart Rhythm 11 4 2014 655 662
5. M.J. Ackerman, S.G. Priori, S. Willems, C. Berul, R. Brugada, and et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the heart rhythm society (HRS) and the European heart rhythm association (EHRA) Heart Rhythm 8 8 2011 1308 1339
6. N. Narula, D.J. Tester, A. Paulmichl, J.J. Maleszewski, and M.J. Ackerman Post-mortem whole exome sequencing with gene-specific analysis for autopsy-negative sudden unexplained death in the young: a case series Pediatr. Cardiol. 36 4 2015 768 778
7. M. Brion, C. Allegue, M. Santori, R. Gil, A. Blanco-Verea, and et al. Sarcomeric gene mutations in sudden infant death syndrome (sids) Forensic Sci. Int. 219 1-3 2012 278 281
8. A.M. Varnava, P.M. Elliott, C. Baboonian, F. Davison, M.J. Davies, and et al. Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin t disease Circulation 104 12 2001 1380 1384
9. P.J. Schwartz, M. Stramba-Badiale, L. Crotti, M. Pedrazzini, A. Besana, and et al. Prevalence of the congenital long-qt syndrome Circulation 120 18 2009 1761 1767
10. P.L. Hedley, P. Jorgensen, S. Schlamowitz, R. Wangari, J. Moolman-Smook, and et al. The genetic basis of long qt and short qt syndromes: a mutation update Hum. Mutat. 30 11 2009 1486 1511
11. G. Sarquella-Brugada, O. Campuzano, E. Arbelo, J. Brugada, and R. Brugada Brugada syndrome: clinical and genetic findings Genet. Med. 2015
12. A.A. Wilde, and E.R. Behr Genetic testing for inherited cardiac disease Nat. Rev. Cardiol. 10 10 2013 571 583
13. Y. Mizusawa, and A.A. Wilde Brugada syndrome Circ. Arrhythm Electrophysiol. 5 3 2012 606 616
14. M. Hayashi, I. Denjoy, F. Extramiana, A. Maltret, N.R. Buisson, and et al. Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia Circulation 119 18 2009 2426 2434
15. A. Pflaumer, and A.M. Davis Guidelines for the diagnosis and management of catecholaminergic polymorphic ventricular tachycardia Heart Lung Circ. 21 2 2012 96 100
16. I. Gussak, P. Brugada, J. Brugada, R.S. Wright, S.L. Kopecky, and et al. Idiopathic short qt interval: a new clinical syndrome? Cardiology 94 2 2000 99 102
17. C. Roma-Rodrigues, and A.R. Fernandes Genetics of hypertrophic cardiomyopathy: advances and pitfalls in molecular diagnosis and therapy Appl. Clin. Genet. 7 2014 195 208
18. C. Semsarian, and J. Ingles Expanding the genetic spectrum of hypertrophic cardiomyopathy: X marks the spot Circ. Cardiovasc. Genet. 6 6 2013 528 530
19. K.E. Berge, and T.P. Leren Genetics of hypertrophic cardiomyopathy in norway Clin. Genet. 86 4 2014 355 360
20. L.R. Lopes, M.S. Rahman, and P.M. Elliott A systematic review and meta-analysis of genotype-phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations Heart 99 24 2013 1800 1811
21. R.E. Hershberger, D.J. Hedges, and A. Morales Dilated cardiomyopathy: the complexity of a diverse genetic architecture Nat. Rev. Cardiol. 10 9 2013 531 547
22. E.M. McNally, J.R. Golbus, and M.J. Puckelwartz Genetic mutations and mechanisms in dilated cardiomyopathy J. Clin. Invest. 123 1 2013 19 26
23. J. Haas, K.S. Frese, B. Peil, W. Kloos, A. Keller, and et al. Atlas of the clinical genetics of human dilated cardiomyopathy Eur. Heart J. 2014
24. C. Basso, B. Bauce, D. Corrado, and G. Thiene Pathophysiology of arrhythmogenic cardiomyopathy Nat. Rev. Cardiol. 9 4 2012 223 233
25. T. Xu, Z. Yang, M. Vatta, A. Rampazzo, G. Beffagna, and et al. Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy J. Am. Coll. Cardiol. 55 6 2010 587 597
26. A. Bhonsale, J.A. Groeneweg, C.A. James, D. Dooijes, C. Tichnell, and et al. Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers Eur. Heart J. 2015 2015
27. m. Authors/Task Force, P.M. Elliott, A. Anastasakis, M.A. Borger, M. Borggrefe, and et al. esc guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the european society of cardiology (esc) Eur. Heart J. 35 39 2014 2733 2779
28. M. Brion, A. Blanco-Verea, B. Sobrino, M. Santori, R. Gil, and et al. Next generation sequencing challenges in the analysis of cardiac sudden death due to arrhythmogenic disorders Electrophoresis 35 21-22 2014 3111 3116
29. Y. Xue, A. Ankala, W.R. Wilcox, and M.R. Hegde Solving the molecular diagnostic testing conundrum for mendelian disorders in the era of next-generation sequencing: Single-gene, gene panel, or exome/genome sequencing Genet. Med. 2014
30. H.L. Rehm Disease-targeted sequencing: a cornerstone in the clinic Nat. Rev. Genet. 14 4 2013 295 300
31. M. Choi, U.I. Scholl, W. Ji, T. Liu, I.R. Tikhonova, and et al. Genetic diagnosis by whole exome capture and massively parallel DNA sequencing Proc. Natl. Acad. Sci. U. S. A. 106 45 2009 19096 19109
32. C. Gilissen, A. Hoischen, H.G. Brunner, and J.A. Veltman Unlocking mendelian disease using exome sequencing Genome Biol. 12 9 2011
33. C. Gilissen, A. Hoischen, H.G. Brunner, and J.A. Veltman Disease gene identification strategies for exome sequencing Eur. J. Hum. Genet. 20 5 2012 490 497
34. M.J. Bamshad, S.B. Ng, A.W. Bigham, H.K. Tabor, M.J. Emond, and et al. Exome sequencing as a tool for mendelian disease gene discovery Nat. Rev. Genet. 12 11 2011 745 755
35. R. Valdes-Mas, A. Gutierrez-Fernandez, J. Gomez, E. Coto, A. Astudillo, and et al. Mutations in filamin c cause a new form of familial hypertrophic cardiomyopathy Nat. Commun. 5 2014 5326
36. L. Mamanova, A.J. Coffey, C.E. Scott, I. Kozarewa, E.H. Turner, and et al. Target-enrichment strategies for next-generation sequencing Nat. Methods 7 2 2010 111 118
37. M. Yeager, N. Xiao, R.B. Hayes, P. Bouffard, B. Desany, and et al. Comprehensive resequence analysis of a 136 kb region of human chromosome 8q24 associated with prostate and colon cancers Hum. Genet. 124 2 2008 161 170
38. K.V. Voelkerding, S. Dames, and J.D. Durtschi Next generation sequencing for clinical diagnostics-principles and application to targeted resequencing for hypertrophic cardiomyopathy: a paper from the 2009 william beaumont hospital symposium on molecular pathology J. Mol. Diagn. 12 5 2010 539 551
39. B. De Wilde, S. Lefever, W. Dong, J. Dunne, S. Husain, and et al. Target enrichment using parallel nanoliter quantitative pcr amplification BMC Genomics 15 2014 184
40. R. Tewhey, J.B. Warner, M. Nakano, B. Libby, M. Medkova, and et al. Microdroplet-based pcr enrichment for large-scale targeted sequencing Nat. Biotechnol. 27 11 2009 1025 1031
41. Illumina Truseq custom amplicon. Available from: http://www.illumina.com/products/truseq-custom-amplicon.html.
42. LifeTechnologies. Ion torrentÔ next-generation sequencing ion ampliseqÔ panels. Available from: http://www.lifetechnologies.com/es/en/home/life-science/sequencing/next-generation-sequencing/ion-torrent-next-generation-sequencing-workflow/ion-torrent-next-generation-sequencing-select-targets/ampliseq-target-selection.html.
43. Qiagen Generead dnaseq custom panel v2. Available from: https://www.qiagen.com/es/products/catalog/sample-technologies/dna-sample-technologies/genomic-dna/generead-dnaseq-custom-panels-v2/.
44. Multiplicon Multiplex amplification of specific targets for resequencing (mastr). Available from: http://www.multiplicom.com/multiplex-amplification-specific-targets-resequencing-mastr.
45. A. Gnirke, A. Melnikov, J. Maguire, P. Rogov, E.M. LeProust, and et al. Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing Nat. Biotechnol. 27 2 2009 182 189
46. M. Margulies, M. Egholm, W.E. Altman, S. Attiya, J.S. Bader, and et al. Genome sequencing in microfabricated high-density picolitre reactors Nature 437 7057 2005 376 380
47. M. Fedurco, A. Romieu, S. Williams, I. Lawrence, and G. Turcatti BTA, a novel reagent for DNA attachment on glass and efficient generation of solid-phase amplified DNA colonies Nucleic Acids Res. 34 3 2006 e22
48. G. Turcatti, A. Romieu, M. Fedurco, and A.P. Tairi A new class of cleavable fluorescent nucleotides: synthesis and optimization as reversible terminators for DNA sequencing by synthesis Nucleic Acids Res. 36 4 2008 e25
49. J. Shendure, G.J. Porreca, N.B. Reppas, X. Lin, J.P. McCutcheon, and et al. Accurate multiplex polony sequencing of an evolved bacterial genome Science 309 5741 2005 1728 1732
50. J.M. Rothberg, W. Hinz, T.M. Rearick, J. Schultz, W. Mileski, and et al. An integrated semiconductor device enabling non-optical genome sequencing Nature 475 7356 2011 348 352
51. J. Eid, A. Fehr, J. Gray, K. Luong, J. Lyle, and et al. Real-time DNA sequencing from single polymerase molecules Science 323 5910 2009 133 138
52. P. Bioscience Smrt sequencing advantage Available from: http://www.pacificbiosciences.com/products/smrt-technology/smrt-sequencing-advantage/.
53. O. Nanopore Available from: https://www.nanoporetech.com/.
54. R. Nielsen, J.S. Paul, A. Albrechtsen, and Y.S. Song Genotype and snp calling from next-generation sequencing data Nat. Rev. Genet. 12 6 2011 443 451
55. R. Bao, L. Huang, J. Andrade, W. Tan, W.A. Kibbe, and et al. Review of current methods, applications, and data management for the bioinformatics analysis of whole exome sequencing Cancer Inform. 2 2014 67 82
56. I.A. Adzhubei, S. Schmidt, L. Peshkin, V.E. Ramensky, A. Gerasimova, and et al. A method and server for predicting damaging missense mutations Nat. Methods 7 4 2010 248 249
57. P. Kumar, S. Henikoff, and P.C. Ng Predicting the effects of coding non-synonymous variants on protein function using the sift algorithm Nat. Protoc. 4 7 2009 1073 1081
58. J.M. Schwarz, D.N. Cooper, M. Schuelke, and D. Seelow Mutationtaster mutation prediction for the deep-sequencing age Nat. Methods 11 4 2014 361 362
59. K.S. Pollard, M.J. Hubisz, K.R. Rosenbloom, and A. Siepel Detection of nonneutral substitution rates on mammalian phylogenies Genome Res. 20 1 2010 110 121
60. D.G. MacArthur, T.A. Manolio, D.P. Dimmock, H.L. Rehm, J. Shendure, and et al. Guidelines for investigating causality of sequence variants in human disease Nature 508 7497 2014 469 476
61. D. Ng, J.J. Johnston, J.K. Teer, L.N. Singh, L.C. Peller, and et al. Interpreting secondary cardiac disease variants in an exome cohort Circ. Cardiovasc. Genet. 6 4 2013 337 346
62. R.C. Green, J.S. Berg, W.W. Grody, S.S. Kalia, B.R. Korf, and et al. Acmg recommendations for reporting of incidental findings in clinical exome and genome sequencing Genet. Med. 15 7 2013 565 574
63. J.A. Anderson, R.Z. Hayeems, C. Shuman, M.J. Szego, and N.et al. Monfared Predictive genetic testing for adult-onset disorders in minors: a critical analysis of the arguments for and against the 2013 guidelines Clin. Genet. 2014
64. A.B. o. Directors Acmg policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing Genet. Med. 17 1 2015 68 69
65. F.M. Facio, K. Lee, and J.M. O'Daniel A genetic counselor's guide to using next-generation sequencing in clinical practice J. Genet. Couns. 23 4 2014 455 462
66. S. Richards, N. Aziz, S. Bale, D. Bick, S. Das, and et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the american college of medical genetics and genomics and the association for molecular pathology Genet. Med. 17 5 2015 405 423
67. L. Refsgaard, A.G. Holst, G. Sadjadieh, S. Haunso, J.B. Nielsen, and et al. High prevalence of genetic variants previously associated with lqt syndrome in new exome data Eur. J. Hum. Genet. 20 8 2012 905 908
68. C. Andreasen, J.B. Nielsen, L. Refsgaard, A.G. Holst, A.H. Christensen, and et al. New population-based exome data are questioning the pathogenicity of previously cardiomyopathy-associated genetic variants Eur. J. Hum. Genet. 21 9 2013 918 928
69. O. Campuzano, C. Allegue, A. Fernandez, A. Iglesias, and R. Brugada Determining the pathogenicity of genetic variants associated with cardiac channelopathies Sci. Rep. 5 2015 7953
70. J.D. Kapplinger, J.R. Giudicessi, D. Ye, D.J. Tester, T.E. Callis, and et al. Enhanced classification of brugada syndrome- and long qt syndrome-associated genetic variants in the scn5a-encoded nav1.5 cardiac sodium channel Circ. Cardiovasc. Genet. 2015
71. R. Walsh, N.S. Peters, S.A. Cook, and J.S. Ware Paralogue annotation identifies novel pathogenic variants in patients with brugada syndrome and catecholaminergic polymorphic ventricular tachycardia J. Med. Genet. 51 1 2014 35 44
72. D. Ruklisa, J.S. Ware, R. Walsh, D.J. Balding, and S.A. Cook Bayesian models for syndrome- and gene-specific probabilities of novel variant pathogenicity Genome Med. 7 1 2015 5